Zobrazeno 1 - 10
of 36
pro vyhledávání: '"E. Comaro"'
Publikováno v:
Annals of Global Health, Vol 82, Iss 3, Pp 601-602 (2016)
Externí odkaz:
https://doaj.org/article/579cb0a633aa403088d3607e2d20bd76
Autor:
B. Montico, C. Lapenta, M. Ravo, D. Martorelli, E. Muraro, B. Zeng, E. Comaro, M. Spada, S. Donati, S. M. Santini, R. Tarallo, G. Giurato, F. Rizzo, A. Weisz, F. Belardelli, R. Dolcetti, J. Dal Col
Publikováno v:
OncoImmunology, Vol 6, Iss 11 (2017)
Although promising, the clinical benefit provided by dendritic cell (DC)-based vaccines is still limited and the choice of the optimal antigen formulation is still an unresolved issue. We have developed a new DC-based vaccination protocol for aggress
Externí odkaz:
https://doaj.org/article/7503526026f44461a3e8c6bbe442d196
Autor:
Damiana Antonia Faè, Riccardo Dolcetti, Debora Martorelli, Luigi Barzan, Carlo Gobitti, E. Comaro, F. Navarria, C. Furlan, Giuseppe Fanetti, Sandro Sulfaro, Elena Muraro, Agostino Steffan, Giovanni Franchin, Chiara Pratesi, Stefania Zanussi, Emanuela Vaccher, Valentina Lupato, Jerry Polesel, Michela Cangemi, Vittorio Giacomarra, Vincenzo Canzonieri, C. Scaini, Giuseppe Grando, Elisabetta Fratta
Publikováno v:
Pathology & Oncology Research. 26:2459-2467
Undifferentiated Nasopharyngeal Carcinoma (UNPC) is associated with Epstein-Barr Virus (EBV) and characterized by an abundant immune infiltrate potentially influencing the prognosis. Thus, we retrospectively assessed the significance of immunosuppres
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dania Benedetti, Giorgio Giurato, Alessandro Weisz, Agostino Steffan, Michele Maio, Alessia Covre, Elisabetta Fratta, E. Comaro, Barbara Montico, Francesca Colizzi, Eliana Pivetta, Luca Sigalotti
Publikováno v:
Cancer Research. 80:B06-B06
Background: Targeted therapy has proven efficacy in BRAF-mutant metastatic cutaneous melanoma (CM), but patients almost invariantly develop an early resistance. Although the underlying mechanisms are various and heterogeneous, resistance usually asso
Autor:
Alessandro Weisz, Filippo Belardelli, Debora Martorelli, E. Comaro, Stefano M. Santini, Bijun Zeng, Barbara Montico, Elena Muraro, Caterina Lapenta, Maria Ravo, Riccardo Dolcetti, J. Dal Col, Francesca Rizzo, Roberta Tarallo, Massimo Spada, Simona Donati, Giorgio Giurato
Publikováno v:
OncoImmunology, Vol 6, Iss 11 (2017)
Although promising, the clinical benefit provided by dendritic cell (DC)-based vaccines is still limited and the choice of the optimal antigen formulation is still an unresolved issue. We have developed a new DC-based vaccination protocol for aggress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ee411b1da5b04768248ba725bf990b
https://europepmc.org/articles/PMC5674955/
https://europepmc.org/articles/PMC5674955/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Samuele Massarut, Debora Martorelli, Anna Carbone, A. Veronesi, Diana Crivellari, Tiziana Perin, Gianmaria Miolo, Riccardo Dolcetti, Elena Muraro, Elisa Turchet, E. Comaro, D. Lombardi, R. Talamini
Publikováno v:
Cancer Research. 71:P3-14
Background: A phase II study was performed to assess the role of patients’ immune profile in the activity of a trastuzumab-based, non anthracycline containing neoadjuvant chemotherapy (NC) regimen in locally advanced breast cancer (BC) patients (pt
Autor:
Elena Muraro, Damiana Antonia Faè, Vincenzo Canzonieri, Giuseppe Grando, V. Lupato, Giovanni Franchin, Elisabetta Fratta, E. Farina, Luigi Barzan, Agostino Steffan, Riccardo Dolcetti, Emanuela Vaccher, Debora Martorelli, Jerry Polesel, Vittorio Giacomarra, E. Comaro, F. Navarria, C. Furlan, Giuseppe Fanetti, Sandro Sulfaro
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:e242
Autor:
Samuele Massarut, Diana Crivellari, Debora Martorelli, Gianmaria Miolo, Elisa Turchet, Tiziana Perin, E. Comaro, Elena Muraro, Simona Scalone, Davide Lombardi, R. Talamini, Simon Spazzapan, Riccardo Dolcetti, Loredana Militello
Publikováno v:
Journal of Translational Medicine
Background Locally advanced HER2-overexpressing breast cancer (BC) patients achieve a high rate of pathological complete responses (pCR) after neoadjuvant chemotherapy (NC). The apparently unaltered immune proficiency of these patients together with